Skip to main content

11 Result(s)

within A. Khammari Remove this filter

and

  1. No Access

    Article

    TOXICAN: a guide for grading dermatological adverse events of cancer treatments

    The dermatological toxicity of cancer treatments is frequent and sometimes debilitating. Its reference classification, the NCI-CTCAE (National Cancer Institute–Common Terminology Criteria for Adverse Events), ...

    L. Peuvrel, J. Cassecuel, C. Bernier, G. Quéreux… in Supportive Care in Cancer (2018)

  2. Article

    Open Access

    Predictors of responses to immune checkpoint blockade in advanced melanoma

    Immune checkpoint blockers (ICB) have become pivotal therapies in the clinical armamentarium against metastatic melanoma (MMel). Given the frequency of immune related adverse events and increasing use of ICB, ...

    N. Jacquelot, M. P. Roberti, D. P. Enot, S. Rusakiewicz, N. Ternès… in Nature Communications (2017)

    Download PDF (976 KB) View Article

  3. No Access

    Article

    Development of brain metastases in patients with metastatic melanoma while receiving ipilimumab

    Ipilimumab is a monoclonal antibody blocking the inhibitory molecule CTLA4 expressed by activated T lympocytes, used for the treatment of metastatic melanoma. Recent studies have shown its potential efficacy o...

    C. Frenard, L. Peuvrel, M. Saint Jean, A. Brocard, A. C. Knol… in Journal of Neuro-Oncology (2016)

  4. No Access

    Article

    Incidence and characteristics of melanoma brain metastases develo** during treatment with vemurafenib

    Vemurafenib is indicated for the treatment of patients with BRAF V600 -mutant metastatic melanoma. We studied for the first time the characteristics of brain met...

    L. Peuvrel, M. Saint-Jean, G. Quéreux, A. Brocard, A. Khammari… in Journal of Neuro-Oncology (2014)

  5. No Access

    Article

    Anti-inflammatory properties of a new undecyl-rhamnoside (APRC11) against P. acnes

    Acne vulgaris is a skin disease affecting pilosebaceous glands in which Propionibacterium acnes (P. acnes) induced inflammation plays a central role. In order to develop new therapies against the inflammatory eve...

    O. Isard, M. Lévêque, A. C. Knol, M. F. Ariès… in Archives of Dermatological Research (2011)

  6. Article

    Physiological apoptosis of polar cells during Drosophila oogenesis is mediated by Hid-dependent regulation of Diap1

    Although much has been learned in recent years about the apoptotic machinery, the mechanisms underlying survival and death choices during development of metazoans remain less clearly understood. During early o...

    A Khammari, F Agnès, P Gandille, A-M Pret in Cell Death & Differentiation (2011)

    Download PDF (5070 KB) View Article

  7. No Access

    Article

    Melanoma gene expression and clinical course

    Evidence for the in vitro lymphocyte response against autologous melanoma has been accumulating over the past 10 years, leading to the identification of numerous melanoma-associated antigens recognised by T ce...

    M. Vourc’h-Jourdain, C. Volteau, J. M. Nguyen… in Archives of Dermatological Research (2009)

  8. No Access

    Article

    Anti-inflammatory effects of lithium gluconate on keratinocytes: a possible explanation for efficiency in seborrhoeic dermatitis

    Topical lithium (Li) gluconate has a beneficial effect on seborrhoeic dermatitis (SD), unlike oral lithium (Li) used in psychiatry. SD is an inflammatory dermatitis associated, in most of cases, with colonizat...

    F. Ballanger, I. Tenaud, C. Volteau, A. Khammari… in Archives of Dermatological Research (2008)

  9. No Access

    Article

    Modulation of integrins and filaggrin expression by Propionibacterium acnes extracts on keratinocytes

    Propionibacterium acnes plays an important role in the pathogenesis of acne and it is established that this bacteria is involved in the induction and maintenance of the inflammatory phase of acne. The aim of our ...

    V. Jarrousse, N. Castex-Rizzi, A. Khammari… in Archives of Dermatological Research (2007)

  10. No Access

    Article

    Loss of oncostatin M receptor β in metastatic melanoma cells

    Oncostatin M (OSM) is an interleukin-6 (IL-6) type cytokine originally described by its capacity to inhibit melanoma proliferation in vitro. Here, the mechanisms involved in resistance to growth inhibition by OSM...

    A Lacreusette, J-M Nguyen, M-C Pandolfino, A Khammari, B Dreno, Y Jacques… in Oncogene (2007)

  11. No Access

    Chapter

    Sézary’s syndrome and human immunodeficiency virus negative Kaposi’s sarcoma

    B. Dréno, A. Khammari in Cutaneous Lymphomas (2001)